Aphelion Capital

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Laplace Interventional is a medical device company specializing in the development of transcatheter tricuspid valve technology. This innovative technology aims to enhance life expectancy and improve the quality of life for patients suffering from tricuspid regurgitation. The company's prosthetic valve is delivered through a minimally invasive procedure, eliminating the need for open-heart surgery. By offering a less invasive treatment option, Laplace Interventional enables healthcare providers to mitigate future complications for patients, thereby contributing to a better overall health outcome.

Venova Medical is a company focused on developing innovative vascular access systems for patients undergoing renal replacement therapy, particularly those requiring hemodialysis. Founded in 2018 and headquartered in Los Gatos, California, Venova Medical aims to improve the quality of vascular access by addressing both patient-level and systemic barriers associated with access creation. The company's solutions are designed to facilitate quickly functioning access with reduced need for medical interventions, ultimately enhancing patient outcomes and lowering costs associated with hemodialysis. Through its advancements, Venova Medical seeks to simplify the process of obtaining vascular access for patients in need of critical renal therapies.

Nectero Medical is a clinical-stage biotechnology company based in Dover, Delaware, founded in 2017. The company is focused on developing a novel treatment aimed at stabilizing the growth of mid-sized abdominal aortic aneurysms and preventing their rupture. Nectero Medical's innovative approach involves delivering a compound with a stabilizing agent directly to the aneurysm site, which inhibits further breakdown of the vessel wall and strengthens it. This treatment enables patients to undergo earlier intervention safely, potentially delaying or eliminating the need for major endovascular or surgical repairs.

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Phagenesis Limited is a medical device company based in Manchester, United Kingdom, founded in 2007. It focuses on developing innovative technology to treat dysphagia, a condition often associated with stroke and brain injuries that impairs safe swallowing. The company's flagship product, Phagenyx, consists of a base station that delivers targeted electrical stimulations to patients while recording and storing their information, and a catheter that is introduced through the nose to stimulate the pharynx. This approach leverages the brain’s neuroplasticity, enabling patients to relearn essential swallowing functions that may have been lost due to brain damage. Phagenesis aims to improve the recovery process for stroke patients in acute care settings by utilizing a method developed by Prof. Shaheen Hamdy of the University of Manchester, which has been validated through publication in reputable scientific and medical journals.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

Elucid is a Boston-based biotechnology and medical technology company dedicated to enhancing cardiovascular diagnostic imaging through machine learning. The company has developed ElucidVivo, the first FDA-cleared software that evaluates plaque vulnerability from a single computed tomography angiography scan, aiding in the assessment of heart attack and stroke risks as well as informing treatment decisions. Elucid's technology enables objective quantification of arterial plaque extent and stability, providing a cost-effective and non-invasive means of capturing essential patient health information. In addition to its proprietary software, Elucid collaborates with pharmaceutical companies, healthcare providers, and research organizations to offer quantitative image analysis services, ultimately aiming to improve patient outcomes in cardiovascular care.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

ExplORer Surgical Corp. is a Chicago-based company that specializes in developing an interactive surgical playbook aimed at enhancing teamwork and efficiency in operating rooms. Founded in 2013, the company offers a software solution that allows healthcare providers to optimize surgical workflows, customize processes based on patient needs and surgeon preferences, and track case progression in real time. This tool facilitates improved communication among surgical teams, enabling them to coordinate activities and manage tools and supplies effectively, ultimately reducing disruptions and waste. Additionally, ExplORer Surgical provides administrators with valuable performance and scheduling data to enhance the quality of care. The company's innovative approach not only supports surgical teams but also assists medical device companies in the efficient rollout of new devices and improves medical education.

MIVI Neuroscience, Inc. is a medical device company based in Eden Prairie, Minnesota, that specializes in developing and commercializing clinical solutions for neurointerventional procedures. Founded in 2013, the company offers a range of innovative products designed to enhance patient outcomes in treating ischemic strokes. Its portfolio includes high flow tubing, diagnostic and guide catheters, distal access catheters, and aspiration pumps, as well as embolic protection and clot retrieval devices. MIVI Neuroscience focuses on providing healthcare professionals with unique tools that aim to improve the safety and efficacy of interventional therapies, ultimately reducing complications and procedure times while expanding treatment options for patients.

Koya Medical, Inc. is a healthcare company based in Oakland, California, founded in 2018. The company specializes in developing innovative wearable therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. Koya Medical's technology offers active compression therapy that enhances mobility and personalized care, addressing limitations commonly associated with traditional compression methods. Its sensor-based closed-loop system provides patient-specific patterned compression, enabling healthcare providers to effectively manage conditions like chronic edema and chronic venous insufficiency. Through its breakthrough treatments, Koya Medical seeks to transform the standard of care for individuals affected by these debilitating conditions.

Orpyx Medical Technologies Inc. is a Calgary-based company that develops innovative mobility sensor devices aimed at supporting diabetic patients in maintaining their mobility. Founded in 2010, the company offers several key products, including the Orpyx SI sensory insoles, which are designed to manage and prevent diabetic foot ulcers and limb loss by capturing real-time data related to pressure, temperature, and movement. Additionally, Orpyx provides Kinetyx, a mobile in-shoe pressure management system that collects clinical plantar pressure data for various applications, including sports medicine and therapeutic use. Another notable product is SurroGait Rx, which assists multiple sclerosis patients in improving their mobility and balance. Orpyx Medical Technologies emphasizes the importance of prevention in healthcare and collaborates with global stakeholders to promote sustainable health solutions.

Zeto Inc. is a medical technology company based in Santa Clara, California, focusing on revolutionizing the field of electroencephalography (EEG). Founded in 2014, Zeto has developed an innovative, FDA-cleared EEG system that features a wireless, easy-to-wear headset equipped with dry electrodes. This system addresses longstanding challenges in traditional EEG procedures, which often require extensive setup time and trained technicians. Zeto's solution allows for a streamlined process, reducing setup time from over 30 minutes to just 5 minutes while enhancing the patient experience. Complementing the headset, Zeto's cloud-based platform facilitates instant data upload, live viewing, and analytical tools, enabling remote interpretation by neurologists. The company has garnered recognition for its contributions to the field, receiving multiple awards and funding, including support from the Epilepsy Foundation and accolades from various medical innovation showcases.

ExplORer Surgical Corp. is a Chicago-based company that specializes in developing an interactive surgical playbook aimed at enhancing teamwork and efficiency in operating rooms. Founded in 2013, the company offers a software solution that allows healthcare providers to optimize surgical workflows, customize processes based on patient needs and surgeon preferences, and track case progression in real time. This tool facilitates improved communication among surgical teams, enabling them to coordinate activities and manage tools and supplies effectively, ultimately reducing disruptions and waste. Additionally, ExplORer Surgical provides administrators with valuable performance and scheduling data to enhance the quality of care. The company's innovative approach not only supports surgical teams but also assists medical device companies in the efficient rollout of new devices and improves medical education.

Bardy Diagnostics, Inc. is a medical technology company focused on developing and manufacturing innovative cardiac monitoring devices. Its flagship product, the Carnation Ambulatory Monitor (CAM), is a lightweight and discreet cardiac patch that can be worn comfortably for up to seven days, even during exercise or showering. The CAM is specifically designed with a narrow, hourglass shape to enhance comfort, particularly for women. This device captures low amplitude and frequency electrical signals that form the P-wave, allowing for accurate arrhythmia detection and improving clinical decision-making. Bardy Diagnostics also offers BDxCONNECT, a patient management system that facilitates the creation, access, and management of patient CAM reports. Founded in 2013 and headquartered in Seattle, Washington, with additional offices in Houston, Texas, and New Providence, New Jersey, Bardy Diagnostics aims to enhance clinical management and outcomes through advanced ECG detection technologies that promote greater patient compliance and more confident diagnoses by physicians.

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

ExplORer Surgical Corp. is a Chicago-based company that specializes in developing an interactive surgical playbook aimed at enhancing teamwork and efficiency in operating rooms. Founded in 2013, the company offers a software solution that allows healthcare providers to optimize surgical workflows, customize processes based on patient needs and surgeon preferences, and track case progression in real time. This tool facilitates improved communication among surgical teams, enabling them to coordinate activities and manage tools and supplies effectively, ultimately reducing disruptions and waste. Additionally, ExplORer Surgical provides administrators with valuable performance and scheduling data to enhance the quality of care. The company's innovative approach not only supports surgical teams but also assists medical device companies in the efficient rollout of new devices and improves medical education.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

CyMedica Orthopedics, Inc. is a medical device company focused on developing and commercializing innovative products for joint injuries and the associated muscle atrophy. Founded in 2013 and based in Scottsdale, Arizona, CyMedica offers a range of orthopedic solutions that utilize proprietary neuromuscular electrical stimulation technology. Its flagship product, e-vive, provides individualized muscle stimulation therapy through a wireless and app-controlled system, allowing patients to engage in their rehabilitation while tracking progress and sharing data with clinicians. Additionally, the company offers a variety of products, including the Conductive garment, which ensures effective muscle activation, the ACL Brace for post-operative support, and The QB1 System, designed to empower patients in overcoming quadricep weakness. These devices aim to stabilize joints, prevent muscle weakening during recovery, and improve patient outcomes while reducing the likelihood of readmission.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

Mercator MedSystems, Inc. is a medical technology company based in Emeryville, California, specializing in catheter-guided microfluid injection systems for the targeted delivery of therapeutic agents across blood vessels. The company offers innovative products, including the Cricket and Bullfrog micro-infusion catheters, which facilitate the direct injection of therapies into deep tissues, thereby enhancing treatment efficacy while minimizing systemic exposure. Mercator's technology addresses various medical conditions, including blood vessel restenosis, peripheral artery disease, and neointimal hyperplasia associated with dialysis access failure. Their micro-infusion devices are designed to deliver drugs, genes, and cells without compromising viability or potency. The company's applications extend to treatments for plaque stabilization, anti-tumor therapies, and regenerative medicine. Founded in 1999, Mercator MedSystems aims to improve patient outcomes through precise and effective therapeutic delivery, ultimately advancing the field of vascular disease management and oncology.

VideoCare, Inc. is a technology company focused on enhancing connectivity between families and their aging loved ones through its innovative video communication solution. Founded in 2011 and based in Menlo Park, California, VideoCare offers a user-friendly touch-screen video system designed for elderly care recipients, eliminating the need for keyboards or technical skills. This system facilitates two-way video connections, allowing users to share photos, videos, and music, as well as track medication and appointments. VideoCare not only enables families to provide remote support and companionship but also assists professionals and care agencies in delivering care and maintaining communication with their clients. Through its technology, VideoCare aims to improve the quality of life for seniors by fostering meaningful connections with family and caregivers.

SurgiQuest, established in 2006 and headquartered in Orange, Connecticut, specializes in technology solutions for minimally invasive surgeries. The company's flagship product is AirSeal, a proprietary system that generates an air curtain to maintain an insufflated and airtight environment during laparoscopic and laparoscopic-assisted procedures. SurgiQuest caters primarily to bariatric, colorectal, general, gynecological, and urologic surgical disciplines.

ClearFlow, Inc. is a medical device company focused on developing technologies to address clinical challenges related to obstructed catheters. The company specializes in active blood and fluid evacuation systems, with its flagship product, the PleuraFlow Active Clearance Technology, designed to maintain chest tube patency following cardiothoracic surgery. This system effectively prevents the retention of blood and fluids in the chest cavity, thereby reducing the risk of post-surgical complications. ClearFlow’s proprietary technology is also being adapted for use in various medical segments, including urinary and gastrointestinal catheters, as well as wound drainage systems. Founded in 2006 and headquartered in Anaheim, California, ClearFlow aims to enhance patient recovery processes and overall surgical outcomes by ensuring optimal catheter performance. The company also operates a service center in Maastricht, the Netherlands.

CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

SurgiQuest, established in 2006 and headquartered in Orange, Connecticut, specializes in technology solutions for minimally invasive surgeries. The company's flagship product is AirSeal, a proprietary system that generates an air curtain to maintain an insufflated and airtight environment during laparoscopic and laparoscopic-assisted procedures. SurgiQuest caters primarily to bariatric, colorectal, general, gynecological, and urologic surgical disciplines.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

Ikanos Communications designs, develops, markets, and sells semiconductors and integrated firmware products for connected home networks worldwide. Its offerings include DSL processors, gateway processors, and multi-mode communications processors supporting various network topologies like Ethernet, PON, DSL, and LTE. Serving network equipment manufacturers, original design manufacturers, and other clients through direct sales and distributors, Ikanos operates as a subsidiary of Qualcomm Atheros since 2015, headquartered in Fremont, California.

OrthoScan, Inc. is a privately held medical device company based in Scottsdale, Arizona, founded in 2002. The company specializes in the development and manufacture of orthopedic imaging devices designed for surgical and clinical environments, with a focus on enhancing anatomical visualization for surgeons. OrthoScan’s product offerings include various surgical imaging solutions, such as the ORTHOSCAN FD PULSE and ORTHOSCAN FD-OR flat detectors, which enable optimal positioning and expanded field of view during procedures. Additionally, the company provides the ORTHOSCAN HD mini C-arm, suitable for fluoroscopic imaging of extremities, and the ORTHOSCAN MOBILE DI unit, which facilitates mobility between different clinical settings, including urgent care centers and athletic venues. OrthoScan has also expanded its product line to include accessories like mini drapes, X-ray protective aprons, and small printer paper. Initially known as American C-Arm, Inc., the company rebranded to OrthoScan, Inc. in June 2007.

Corium International, Inc. is a biopharmaceutical company based in Menlo Park, California, specializing in the development, manufacture, and commercialization of specialty pharmaceutical products utilizing transdermal and transmucosal delivery systems. The company offers several products, including the Clonidine Transdermal Delivery System for hypertension and Fentanyl Transdermal Delivery System for chronic pain management. Corium's pipeline includes the Twirla contraceptive patch, MicroCor hPTH(1-34) for osteoporosis, and transdermal systems for Alzheimer's disease treatment. Additionally, the company is developing Aripiprazole and Corplex Ropinirole patches targeting psychiatric disorders and Parkinson's disease, respectively. Corium has established collaborations with several pharmaceutical companies and aims to enhance therapeutic options in central nervous system healthcare. The firm has been operational since 1995 and continues to advance its innovative drug delivery technologies.

StrataGent Life Sciences, Inc. is a specialty drug therapy company focused on developing painless and non-invasive delivery methods for therapeutic treatments that typically require injection. The company's innovative approach utilizes proprietary microjet technology to administer both large and small therapeutic molecules without the need for any device to penetrate the skin. This method aims to enhance patient comfort and adherence to treatment protocols. In recognition of its pioneering work, StrataGent received a $2 million award from the Advanced Technology Program at the National Institute of Standards and Technology in May 2004 to further advance its microjet technology.

VasoNova, Inc. is a medical device manufacturer based in Sunnyvale, California, specializing in vascular navigation systems for healthcare providers and clinicians. The company is known for its innovative self-guided PICC catheter and the VasoNova Vascular Positioning System, which employs an algorithm-based approach to facilitate the optimal placement of vascular access devices. Through its advanced technologies, VasoNova aims to enhance the efficiency and accuracy of vascular access procedures in clinical settings.

Insulet Corporation, established in 2000, specializes in the development, manufacturing, and sale of insulin delivery systems for individuals with insulin-dependent diabetes. Its flagship product, the Omnipod System, comprises a self-adhesive, disposable, and tubeless device worn on the body for up to three days, along with a wireless, handheld personal diabetes manager. The company primarily sells its products through independent distributors, pharmacies, and directly to patients, with a presence in the United States, Canada, Europe, and the Middle East. Insulet's mission is to enhance the lives of people with diabetes by providing a user-friendly, pain-free, and automated insulin delivery solution.

Ikanos Communications designs, develops, markets, and sells semiconductors and integrated firmware products for connected home networks worldwide. Its offerings include DSL processors, gateway processors, and multi-mode communications processors supporting various network topologies like Ethernet, PON, DSL, and LTE. Serving network equipment manufacturers, original design manufacturers, and other clients through direct sales and distributors, Ikanos operates as a subsidiary of Qualcomm Atheros since 2015, headquartered in Fremont, California.

Silicon Access Networks is a provider of an ultra-high performance chipsets for terabit routers and communication silicon to the networking and telecommunications market.